Geoffrey L. Hammond

Geoffrey L. Hammond

Auto-generated profile, based on publicly available information

Geoffrey L. Hammond

Departments of Cellular and Physiological Sciences and Obstetrics and Gynaecology, The University of British Columbia, Vancouver, British Columbia, Canada

Research Focus & Metrics

Academic Career Length

51Years (1976-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2016 in Journal of Endocrinology
Verified
Journal Article
Open access
PDF file
GHGeoffrey L. Hammond
Geoffrey L. Hammond
Biologically active steroids are transported in the blood by albumin, sex hormone-binding globulin (SHBG), and corticosteroid-binding globulin (CBG). These plasma proteins also regulate the non-protein-bound or ‘free’ fractions of circulating steroid hormones that are considered to be biologically active; as such, they can be viewed as the ‘primary gatekeepers of steroid action’. Albumin binds steroids with limited specificity and low affinity, but its high concentration in blood buffers major fluctuations in steroid concentrations and their free fractions. By contrast, SHBG and CBG play much more dynamic roles in controlling steroid access to target tissues and cells. They bind steroids with high (~nM) affinity and specificity, with SHBG binding androgens and estrogens and CBG binding glucocorticoids and progesterone. Both are glycoproteins that are structurally unrelated, and they function in different ways that extend beyond their transportation or buffering functions in the blood. Plasma SHBG and CBG production by the liver varies during development and different physiological or pathophysiological conditions, and abnormalities in the plasma levels of SHBG and CBG or their abilities to bind steroids are associated with a variety of pathologies. Understanding how the unique structures of SHBG and CBG determine their specialized functions, how changes in their plasma levels are controlled, and how they function outside the blood circulation provides insight into how they control the freedom of steroids to act in health and disease.

25 May 2011 in Biology of Reproduction
Verified
Journal Article
Open access
PDF file
GHGeoffrey L. Hammond
Geoffrey L. Hammond
Sex hormone-binding globulin (SHBG) transports androgens and estrogens in blood and regulates their access to target tissues. Hepatic production of SH

1 February 1990 in Endocrine Reviews
Verified
Journal Article
Closed access
PDF file
GHGeoffrey L. Hammond
Geoffrey L. Hammond
I. Introduction AVARIETY of extracellular binding proteins enhance the solubility of steroid hormones in biological fluids and facilitate their transport from steroidogenic tissues to target cells (1). In mammals, albumin is quantitatively the most important of these proteins and provides a large reservoir of loosely bound hormone that may be released within some target tissues (2). Two albumin-related proteins, vitamin D binding protein and α-fetoprotein, also appear to have arisen by duplication of a common ancestral gene (3) and are characterized by higher affinities and specificities for steroid ligands. The molecular composition and structure of the vitamin D binding protein have already been described in detail (4), and this review will concentrate on the molecular properties of two other biologically important classes of extracellular steroid binding proteins: corticosteroid binding globulin (CBG) and the sex-steroid binding proteins; sex hormone binding globulin (SHBG) and androgen binding protein (ABP). These proteins are far less abundant than those of the albumin superfamily, but they bind biologically active steroid hormones with remarkably high affinity and specificity. As a result, they not only transport steroid hormones but also modulate steroid bioavailability (5), and may participate directly in the delivery of steroids to certain cells by interaction with plasma membrane receptors (6). Indeed, it is becoming increasingly obvious that their activities may be attributed to unique structural properties; a greater understanding of which may help define their physiological importance.

7 October 2002 in British Journal of Cancer
Verified
Journal Article
Open access
PDF file
NBN F Boyd
N F Boyd
JSJennifer Stone
Jennifer Stone
LML J Martin
L J Martin
RJR Jong
R Jong
EFE Fishell
E Fishell
SMS Minkin
S Minkin
Radiologically dense breast tissue (mammographic density) is strongly associated with risk of breast cancer, but the biological basis for this association is unknown. In this study we have examined the association of circulating levels of hormones and growth factors with mammographic density. A total of 382 subjects, 193 premenopausal and 189 postmenopausal, without previous breast cancer or current hormone use, were selected in each of five categories of breast density from mammography units. Risk factor information, anthropometric measures, and blood samples were obtained, and oestradiol, progesterone, sex hormone binding globulin, growth hormone, insulin-like growth factor-I and its principal binding protein, and prolactin measured. Mammograms were digitised and measured using a computer-assisted method. After adjustment for other risk factors, we found in premenopausal women that serum insulin-like growth factor-I levels, and in postmenopausal women, serum levels of prolactin, were both significantly and positively associated with per cent density. Total oestradiol and progesterone levels were unrelated to per cent density in both groups. In postmenopausal women, free oestradiol (negatively), and sex hormone binding globulin (positively), were significantly related to per cent density. These data show an association between blood levels of breast mitogens and mammographic density, and suggest a biological basis for the associated risk of breast cancer.

1 July 1990 in The Journal of Clinical Endocrinology & Metabolism
Verified
Journal Article
Closed access
PDF file
GHGeoffrey L. Hammond
Geoffrey L. Hammond
CSCarolyn L. Smith
Carolyn L. Smith
NPNigel A. M. Paterson
Nigel A. M. Paterson
WSWilliam J. Sibbald
William J. Sibbald
In human blood, cortisol is transported by a plasma protein known as corticosteroid-binding globulin (CBG). As anticipated from primary structure comparisons of CBG and α1-proteinase inhibitor (A1-PI), CBG acts as a substrate for neutrophil elastase. However, unlike A1-PI, CBG does not alter the activity of this enzyme, but is cleaved by it at a single location close to its carboxy-terminus, and this reduces its molecular size by 5 kDa with the concomitant release of more than 80% of CBG-bound cortisol. Three small molecular size fragments are detected after elastase cleavage, and carbohydrate analysis of these fragments suggests that they represent the same polypeptide fragment which has been differentially glyco-sylated. To assess the biological significance of these observations, CBG was incubated with either mononuclear cells or granulocytes obtained from patients with acute inflammation (sepsis) and from a normal volunteer. Only granulocytes from septic patients reduced the mol wt of CBG by about 5 kDa and destroyed its steroid-binding activity. Preincubation with A1-PI prevented this, which demonstrates that neutrophil elastase plays a key role in this event. These results suggest a physiological role for CBG in the delivery of cortisol to sites of inflammation.

1 January 1982
Verified
Book Chapter
Closed access
PSPentti K. Siiteri
Pentti K. Siiteri
JMJames T. Murai
James T. Murai
WRWilliam J. Raymoure
William J. Raymoure
RKRobert W. Kuhn
Robert W. Kuhn
GHGeoffrey L. Hammond
Geoffrey L. Hammond
JNJeffrey A. Nisker
Jeffrey A. Nisker